Austin, TX 10/16/2007 9:11:33 PM
Speak with other shareholders about: (OTCBB: POSC), (NYSE: PLL), (NYSE: MDT), and (Nasdaq: KYPH) .
AUSTIN, TX: October 16, 2007 – Are you looking to speak with other investors about your favorite stock? Stockwire.com, ranked in the top 5,000 websites in the United States by Alexa.com/Amazon.com, has created one of the finest chat programs available for investors. Now you can chat real-time with like-minded individuals about your favorite stock. Visit Stockwire.com and click the “Chat Live” button at the top.
----------------------------------------------------------
Chat real-time with other investors about this POSC news release, by clicking this link: http://www.stockwire.com/POSC
To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=POSC
Positron Corporation (OTCBB: POSC)
Oct. 15, 2007 - Positron Corporation announced today the recent hiring of Mr. Kal Fishman as its new Vice President of Sales and Marketing. Mr. Fishman will be responsible for Sales and Marketing for both IS2 Medical Systems and Positron Corporation products.
Mr. Fishman's experience includes Head of Sales and Marketing for the Pre-Clinical Imaging Division of Siemens Molecular Imaging and Global Product Manager, PET/CT workstations/Six-Sigma Black Belt of General Electric Medical Systems. Mr. Fishman also served in various leadership roles at Elscint, Inc. and the Israeli Air-Force, where he headed various engineering teams & programs.
Positron Corporation's President, Mr. Joseph Oliverio, stated, "The addition of Mr. Fishman to our team provides us with valuable experience from both GE Healthcare and Siemens Medical Solutions. We are confident that Fishman will help us accelerate sales of IS2 products, launch our new low-cost PET systems and future novel product lines."
Fishman stated, "The current market conditions necessitate a dynamic & cutting-edge medical imaging vendor that is primarily customer-centric and technology driven. I am very excited and honored by the opportunity to be a part of the Positron team, which I believe will change the paradigm in the medical imaging marketplace through its people, cutting-edge technology, and by reviving the true meaning of customer-centricity."
(POSC closed Monday @ .06 cents a share.)
----------------------------------------------------------
Chat real-time with other investors about this PLL news release, by clicking this link: http://www.stockwire.com/PLL
To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=PLL
Pall Corporation (NYSE: PLL)
Oct. 15, 2007 - The Board of Directors of Pall Corporation today declared a dividend of $0.12 per share payable on November 12, 2007 to shareholders of record as of October 29, 2007. It is the fourth dividend declared this calendar year. The most recent previous dividend was announced on September 21, 2007 and is payable on October 19.
About Pall Corporation
Pall Corporation is the global leader in the rapidly growing field of filtration, separation and purification. Pall is organized into two businesses: Life Sciences and Industrial. These businesses provide leading-edge products to meet the demanding needs of customers in biotechnology, pharmaceutical, transfusion medicine, energy, electronics, municipal and industrial water purification, aerospace, transportation and broad industrial markets. Total revenues for fiscal year 2007 were $2.2 billion. The Company headquarters is in East Hills, New York with extensive operations throughout the world. For more information visit Pall at http://www.pall.com.
(PLL closed Monday @ $39.79 per share.)
----------------------------------------------------------
Chat real-time with other investors about this MDT news release, by clicking this link: http://www.stockwire.com/MDT
To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=MDT
Medtronic, Inc. (NYSE: MDT) and Kyphon Inc. (Nasdaq: KYPH)
Oct. 15, 2007 - Medtronic, Inc. and Kyphon Inc. announced today, in connection with their previously announced intention to provide a regulatory update at the time of the Kyphon stockholders' special meeting, that antitrust clearances in Spain, Austria and Cyprus have been obtained in connection with the previously announced merger agreement between Medtronic and Kyphon. Consummation of the transaction remains subject to customary closing conditions, including receipt of stockholder approval and clearance from antitrust authorities in Portugal and Turkey. The initial statutory review periods in both of these jurisdictions are scheduled to expire later this month unless the antitrust authorities extend the relevant periods. The parties intend to consummate the transaction reasonably promptly following the receipt of the required antitrust clearances in Portugal and Turkey and the satisfaction of the other customary closing conditions contained in the merger agreement, but in no event prior to November 1. A special meeting of Kyphon's stockholders to vote on the proposed merger has been called for October 16, 2007.
(MDT closed down 11.24% @ $50.00 per share while their vol. was up 700% above their 3 mos. Average.) (KYPH closed @ $70.57 per share, after experiencing an approx. 40% drop in their average vol. *711,151 shares traded, compared to their average of 1,352,900.)
----------------------------------------------------------
As a trader, a very intelligent place to put your money, is where the money is flowing into. These are the kind of trades that you want to get into.
As the saying goes...follow the money!
To see the complete Movers & Shakers Blog go to: http://www.stockwire.com .
About Stockwire:
Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.
The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.
Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.
As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.
While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE RESEARCH GROUP INC..
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the National Association of Securities Dealers ("NASD") at www.nasd.com. The NASD has published information on how to invest carefully at its web site.
Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml
Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.
From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.
Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com, which is owned by Stockwire Research Group Inc. (SRGI). To the degrees enumerated herein, this newsletter and website should not be regarded as an independent publication.
All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company on Stockwire.com is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE.COM.
We often accept restricted shares of company stock; by SEC regulations, restricted shares cannot be sold into the market for a period of at least one year from the time that the shares are issued. In such cases, we detail in the Disclaimer the specific term of any restrictions. We also receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. In such circumstances, we specify on our Disclaimer the terms of the options received. On occasion, we also accept free-trading shares in a company that we cover. We intend to sell these shares at any given time.
While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm .
The Stockwire Group .
512.358.8440 .
info@stockwire.com .
